secwatch.observer — SEC 8-K summary
======================================

Issuer:     Z Squared Inc. (ZSQR)
CIK:        0001759186
Form:       8-K
Filed at:   2025-04-28T23:59:59+00:00
Accession:  0001683168-25-002856
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coeptis Therapeutics to merge with Dogecoin miner Z Squared; biopharma spun out
-------------------------------------------------------------------------------

- Coeptis to spin out biopharma; Z Squared becomes wholly-owned subsidiary focused on Dogecoin mining.
- Z Squared shareholders receive Coeptis equity for 9,000 DOGE mining machines; minimum asset value of $660.3M required.
- Post-close leadership: Z Squared CEO David Halabu becomes CEO; Michelle Burke COO; Dave Mehalick exits board.
- Closing expected Q3 2025; conditions include shareholder and regulatory approvals and Nasdaq listing.
- Combined company to rebrand as Z Squared, aiming to be largest U.S. publicly-traded Dogecoin miner.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759186/000168316825002856/0001683168-25-002856-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759186/000168316825002856/coeptis_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-002856

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer